Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study
Eric D McCollum,
Bejoy Nambiar,
Rashid Deula,
Beatiwel Zadutsa,
Austin Bondo,
Carina King,
James Beard,
Harry Liyaya,
Limangeni Mankhambo,
Marzia Lazzerini,
Charles Makwenda,
Gibson Masache,
Naor Bar-Zeev,
Peter N Kazembe,
Charles Mwansambo,
Norman Lufesi,
Anthony Costello,
Ben Armstrong and
Tim Colbourn
PLOS ONE, 2017, vol. 12, issue 1, 1-17
Abstract:
Background: The pneumococcal conjugate vaccine’s (PCV) impact on childhood pneumonia during programmatic conditions in Africa is poorly understood. Following PCV13 introduction in Malawi in November 2011, we evaluated the case burden and rates of childhood pneumonia. Methods and Findings: Between January 1, 2012-June 30, 2014 we conducted active pneumonia surveillance in children 75% three-dose PCV13 coverage (post). We also used multivariable time-series regression, adjusting for autocorrelation and exploring seasonal variation and alternative model specifications in sensitivity analyses. Conclusions: Thirty months after PCV13 introduction in Malawi, the health system burden and rates of the severest forms of childhood pneumonia, including hypoxemia and death, have markedly decreased.
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168209 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 68209&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0168209
DOI: 10.1371/journal.pone.0168209
Access Statistics for this article
More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().